Cyclopharm Limited (ASX:CYC)
Australia flag Australia · Delayed Price · Currency is AUD
0.9400
+0.0100 (1.08%)
Feb 11, 2026, 1:44 PM AEST

Cyclopharm Cash Flow Statement

Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-13.38-13.2-4.7-6.61-5.04-6.04
Depreciation & Amortization
1.591.480.940.930.760.91
Asset Writedown & Restructuring Costs
---3.16---
Other Operating Activities
0.681.750.90.520.751.01
Change in Accounts Receivable
0.840.84-0.49-0.590.69-1.78
Change in Inventory
-3.09-3.09-1.86-2.78-0.78-2.24
Change in Accounts Payable
0.270.270.930.891.452.13
Change in Unearned Revenue
---000.1
Change in Income Taxes
-0.19-0.19-0.050.040.160.08
Change in Other Net Operating Assets
-0.45-0.450.420.740.02-3.12
Operating Cash Flow
-13.71-12.57-7.2-6.66-1.63-8.93
Capital Expenditures
-0.65-0.8-0.24-1.27-0.84-0.19
Cash Acquisitions
--0.03---0.34
Sale (Purchase) of Intangibles
-0.16-0.17-0.3-0.27-0.32-0.34
Investing Cash Flow
-0.8-0.97-0.51-1.55-1.16-0.87
Long-Term Debt Repaid
--0.64-0.28-0.29-0.29-0.29
Net Debt Issued (Repaid)
-0.88-0.64-0.28-0.29-0.29-0.29
Issuance of Common Stock
-24.010.140.45330.06
Common Dividends Paid
---0.88-0.88-0.88-0.75
Other Financing Activities
-0.08-1.14---1.66-
Financing Cash Flow
-0.9722.22-1.02-0.7330.17-0.99
Foreign Exchange Rate Adjustments
0.330.170.16-0.01-0.010.01
Net Cash Flow
-15.158.84-8.57-8.9527.37-10.79
Free Cash Flow
-14.36-13.38-7.43-7.94-2.47-9.13
Free Cash Flow Margin
-46.73%-48.52%-28.23%-31.94%-12.36%-51.63%
Free Cash Flow Per Share
-0.13-0.13-0.08-0.09-0.03-0.12
Cash Interest Paid
0.320.320.320.270.090.21
Cash Income Tax Paid
0.370.30.3-3.42-2.730.25
Levered Free Cash Flow
-13.26-10.21-6.63-5.97-0.81-7.31
Unlevered Free Cash Flow
-12.96-10.03-6.51-5.8-0.75-7.18
Change in Working Capital
-2.61-2.61-1.18-1.51.9-4.81
Source: S&P Global Market Intelligence. Standard template. Financial Sources.